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a b s t r a c t
Dysferlin is a calcium-binding transmembrane protein involved in membrane fusion and membrane
repair. In humans, mutations in the dysferlin gene are associated with muscular dystrophy. In this study,
we isolated plasma membrane-enriched fractions from full-grown immature oocytes of the sea star, and
identiﬁed dysferlin by mass spectrometry analysis. The full-length dysferlin sequence is highly conserved
between human and the sea star. We learned that in the sea star Patiria miniata, dysferlin RNA and
protein are expressed from oogenesis to gastrulation. Interestingly, the protein is highly enriched in the
plasma membrane of oocytes. Injection of a morpholino against dysferlin leads to a decrease of
endocytosis in oocytes, and to a developmental arrest during gastrulation. These results suggest that
dysferlin is critical for normal endocytosis during oogenesis and for embryogenesis in the sea star and
that this animal may be a useful model for studying the relationship of dysferlin structure as it relates to
its function.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Dysferlin is a transmembrane protein associated with rare
forms of muscular dystrophies, such as limb-girdle muscular
dystrophy type 2B (Bashir et al., 1998), Miyoshi myopathy (Liu
et al., 1998), and distal myopathy (Illa et al., 2001). Loss of dysferlin
from the plasma membrane of muscle ﬁbers leads to abnormalities
in vesicular trafﬁcking and membrane repair (Kobayashi et al.,
2012). Moreover, freshly isolated monocytes of dysferlino-
pathy patients show deregulated expression of ﬁbronectin and
ﬁbronectin-binding integrins which is recapitulated by transient
knockdown of dysferlin in the human monocytic cell line, THP1.
Dysferlin regulates cellular interactions by forming a complex with
integrins at the cell membrane (de Morree et al., 2013). In humans,
the dysferlin transcript is highly expressed in skeletal muscle,
heart, placenta, and more weakly in liver, lung, kidney and
pancreas (Bashir et al., 1998). More recently, it was also found in
cultured vascular endothelial cells (Leung et al., 2011; Sharma
et al., 2010). Dysferlin is a member of the ferlin family of proteins,
based on the similarity to the C. elegans protein Fer-1 (Fertilization
defective-1). In C. elegans, the full-length dysferlin homolog Fer-1
(230 kDa) is present early in spermatogenesis and becomes less
abundant in spermatids, perhaps because it is proteolytically
processed into smaller isoforms (195 and 180 kDa) (Washington
and Ward, 2006). Fer-1 is required for the fusion of specialized
vesicles, called membranous organelles, with the plasma mem-
brane during spermatogenesis (Achanzar and Ward, 1997;
Washington and Ward, 2006).
Two other ferlin proteins have been identiﬁed in humans,
myoferlin and otoferlin. Myoferlin was ﬁrst considered as a muscle
speciﬁc protein and its deletion results in impaired mouse myo-
blast fusion into mature skeletal myotubes (Doherty et al., 2005).
However, myoferlin has been shown to be critical for endocytosis
in endothelial cells (Bernatchez et al., 2009). Myoferlin is also
abundantly expressed in invasive breast tumor cells and remark-
ably, its depletion stalls the invasion of these cells (Li et al., 2012).
Otoferlin is essential for hearing and pathogenic mutations are
associated with nonsynchronic autosomal recessive deafness
(Yasunaga et al., 1999). Otoferlin is required in the priming and
fusion of synaptic vesicles during sound encoding, which occurs at
synapses between cochlear inner hair cells and the auditory nerve
(Pangrsic et al., 2012).
Ferlin proteins function in various developmental and repro-
ductive processes in several organisms. While dysferlin and
myoferlin are co-expressed in the human placenta, only dysferlin
expression is positively correlated to cell fusion in trophoblastic
cells (Robinson et al., 2009). In Drosophila melanogaster, only one
ferlin gene, called misﬁre (mfr), has been found. The transcript is
expressed in the testis and ovaries of adult ﬂies. In males, mfr
expression is required for efﬁcient breakdown of the sperm
plasma membrane and completion of sperm activation during
fertilization. In females, it is required for egg patterning by limiting
the spread of proteins such as Gurken. Mutations in misﬁre delay
embryogenesis (Ohsako et al., 2003; Smith and Wakimoto, 2007).
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
0012-1606/$ - see front matter & 2014 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ydbio.2013.12.018
n Correspondence to: 185 Meeting Street, Box G, Brown University, Providence,
RI 02912, USA.
E-mail address: rhet@brown.edu (G.M. Wessel).
1 Current address: Department of Natural Sciences, LaGuardia Community
College, Long Island City, NY 11101.
2 Current address: Instituto de Bioquímica Médica, Universidade Federal do Rio
de Janeiro, RJ 21940-590, Brazil.
Developmental Biology 388 (2014) 94–102
In zebraﬁsh, the dysferlin transcript is ﬁrst detected at 11 h post-
fertilization, remains detectable until 96 h, and is expressed in
different tissues including muscle, brain and eye (Kawahara et al.,
2011). Reduction of dysferlin expression in this animal by mor-
pholino injection causes abnormal formation of muscle structures
(Kawahara et al., 2011). The dysferlin gene is also present in the sea
urchin genome (Sodergren et al., 2006) and this animal was used
to test the role of dysferlin in membrane healing (Covian-Nares
et al., 2010). Laser wounding of one cell in a 4-cell stage embryo
triggered calcium spikes in neighboring cells through voltage-
gated calcium channels whereas embryos injected with a dysferlin
morpholino lost their calcium spike activity in neighboring cells
after wounding. The authors conclude that the dysferlin-depleted
embryos have lost an ability to receive a signal, possibly a
nucleotide, released by the wounded cell.
Here, we found that dysferlin is enriched in the plasma mem-
branes of oocytes and embryos from the sea star, an animal with
oocytes and embryos tractable for studying cellular dynamics
(Fresques et al., in press; Hinman et al., 2003a; Wessel et al., 2010).
Sea stars are invertebrate deuterostomes, a sister group to chordates.
Oocytes, eggs and embryos of the species used here, Patiria miniata,
are optically clear, enabling excellent observations of development.
Developing oocytes are plentiful, manipulatable, are arrested in
prophase of ﬁrst meiotic division and meiotic reinitiation is induced
by the hormone 1-methyladenine (Kanatani et al., 1969). After
fertilization, embryos develop quickly, reach the blastula stage in
one day, and gastrulate in two days. In this study, we show that in the
starﬁsh Patiria miniata (Pm), knockdown of the dysferlin protein
results in reduced endocytosis during oogenesis and signiﬁcant
developmental defects in embryos.
Materials and methods
Animals
P. miniata and A. forbesi were housed in aquaria with artiﬁcial
seawater (ASW) at 16 1C (Coral Life Scientiﬁc Grade Marine Salt;
Carson, CA). Gametes were acquired by opening up the animals.
Oocytes were collected in ﬁltered seawater and sperm was collected
dry. To obtain mature oocytes, the full-grown immature oocytes
were incubated for an hour in ﬁltered sea water containing 2 mM 1-
methyladenine. After addition of sperm, fertilized eggs were cultured
in ﬁltered seawater at 16 1C (Foltz et al., 2004; Wessel et al., 2010).
Isolation of plasma membrane-enriched fractions
Full-grown immature or mature oocytes were isolated in
Calcium-Free Sea Water (CFSW), resuspended in buffer A (Sucrose
0.36 M, 50 mM Tris pH8, 5 mM EDTA) and homogenized on ice by
ﬁve up and down strokes of a loose-ﬁtting glass pestle in a 40 mL
glass dounce tissue grinder. Following a 15-min incubation on ice,
the sample was homogenized with an additional ﬁve strokes and
the homogenate was then incubated at 4 1C overnight to settle the
plasma membrane-enriched fraction (PMEF) by gravity. This frac-
tion was washed three times with buffer A and the membranes
were collected for analysis, or pelleted in a microfuge at 14 000 g
for 5 min. For SDS-PAGE, the pellet was resuspended in Laemmli
Sample Buffer (LSB) containing 5 mM DTT, and the samples were
boiled for 5 min at 100 1C.
Rhodamine-B-Isothiocynate (RITC) labeling of oocyte surface proteins
Full-grown immature oocytes were isolated in CFSW and all
labeling steps were performed in CFSW. Oocytes were pelleted by
gentle centrifugation and rotated at 16 1C for about 90 min in a
15 ml conical centrifuge tube containing RITC at 0.5 µg/ml in
CFSW. Oocytes were then rinsed with ﬁltered SW from the Marine
Biological Laboratories (MBL; Woods Hole, MA) three times. An
aliquot (200 μl) of RITC-labeled whole oocytes was pelleted and
suspended in 200 μl of 2 LSB containing 5 mM DTT for SDS-
PAGE analysis. PMEFs were isolated from these labeled oocytes
using the protocol described above. Images were taken with a
ﬂuorescence dissecting stereoscope (Olympus SZX16) connected
to an Olympus X cite 120 lamp and to a camera (Nikon D90),
managed by Pro 2 software. Samples were electrophoresed
through a 4%–12% SDS-PAGE, stained with Coomassie Brilliant
Blue for 1 h and the RITC signal was detected using a Typhoon
Imager (GE Healthcare, Typhoon 9410).
Mass spectrometry and protein analysis
PMEF was loaded on a SDS-PAGE for Coomassie Brilliant Blue
staining. The two main high molecular weight proteins were
obtained and processed for in gel digestion using the In gel tryptic
digestion kit (Pierce). Proteins were digested overnight at 37 1C in
presence of 10 ng/ml trypsin. Samples were analyzed using a
Thermo-Finnigan LTQ linear ion trap mass spectrometer. Tryptic
peptides were fractionated on a reversed phase column and
introduced directly onto an LTQ mass spectrometer via electrospray
ionization. Pm-dysferlin was identiﬁed via database matching with
the program SEQUEST (Eng et al., 1994), using the Pm ovary
transcriptome (Adrian Reich and Gary Wessel, unpublished data)
which has been entered at NCBI (KJ081282).
EMBOSS Needle was used to obtain protein identities and
similarities between the species (EMBL-EBI). SOSUI was used to
identify the transmembrane domains (Mitaku et al., 2002). Con-
served Domain Database (CDD) was used to identify the protein
domains (Marchler-Bauer et al., 2011). The DysF domains of the
human dysferlin protein were also deﬁned according to a previous
analysis (Lek et al., 2010). YinOYang (Gupta and Brunak, 2002),
NetPhos (Blom et al., 1999), Sulﬁnator (Monigatti et al., 2002), and
ProP (Duckert et al., 2004) were used to analyze the potential post-
translational modiﬁcations of the proteins.
Antibody production
Rabbit polyclonal antibody against the peptide sequence
ALPRPKFSDSTGKI of dysferlin from P. miniata was custom devel-
oped and afﬁnity puriﬁed by GenScript (Piscataway, NJ). This
peptide, speciﬁc to dysferlin, is located in the DysFN domain
(amino-acids 889–902).
Western blot
Western blot analysis was performed following electrophoretic
transfer of proteins from SDS-PAGE onto 0.22 μm nitrocellulose
membranes (Towbin et al., 1979). Membranes were incubated with
antibodies directed against Pm-dysferlin (1/5000) in 20 mM Tris–
HCl (pH7.6), 3% BSA, and 0.1% Tween-20, overnight at 4 oC. The
antigen–antibody complex was measured by chemiluminescence
using horseradish peroxidase-coupled secondary antibodies
according to the manufacturer0s instruction (ECL; GE Healthcare
Biosciences, Pittsburgh, PA, USA).
Real-time quantitative PCR (QPCR)
RNA was extracted from the different developmental stages using
the RNeasy Micro Kit (Qiagen; Valencia, CA). cDNAwas prepared using
the TaqMans Reverse Transcription Reagents kit (Applied Biosystems;
Foster City, CA). QPCR was performed on a 7300 Real-Time PCR system
(Applied Biosystems; Foster City, CA) with the FastStart Universal
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SYBR Green Master Kit (Roche). Pm-dysferlin was ampliﬁed using
the following primers: F (5-AACGAAGCCCTGGAAGAGAT-30) and R
(50-GCATGGAGACCGGAGTAGAG-30). Experiments were run in tripli-
cate, and the data were normalized to ubiquitin RNA levels (Hinman
and Davidson, 2003; Hinman et al., 2003b). Pm-ubiquitin was ampli-
ﬁed using the primers F (50-TTCGGTGAAAGCCAAGATTC-30) and R
(50-CCCACCTCTCATGGCTAGAA-30).
Whole mount RNA in situ hybridization (WMISH)
The sequence used to make antisense WMISH probes for Pm-
dysferlin was ampliﬁed from Pm ovary cDNA and cloned into
pGEM T-Easy (Promega). Pm-dysferlin was ampliﬁed using the
following primers: F (50-ATACGCGTGTGGGTTGCCTGG-30) and R
(50-AGCGCGCTACACGCTGATCG-30). The pGEM T-Easy plasmids were
linearized using NdeI (T7 transcription) (Promega; Madison, WI).
Antisense, DIG-labeled RNA probes were constructed using a DIG
RNA labeling kit (Roche; Indianapolis, IN). WMISH experiments were
performed as described previously (Minokawa et al., 2004), and the
alkaline phosphatase reaction was carried out for 1 h. A non-speciﬁc
DIG-labeled RNA probe complementary to neomycin resistance gene,
obtained from the pSport 18 (Roche; Indianapolis, IN) was used as a
negative control. Samples were imaged on a Zeiss Axiovert 200 M
microscope equipped with a Zeiss color AxioCam MRc5 camera
(Carl Zeiss, Inc.; Thornwood, NY).
Immunoﬂuorescence
Oocytes and embryos were cultured as described above, and
samples were collected at the indicated stages for whole-mount
antibody labeling. The fertilization envelope was manually removed
in the early stages. Cells were ﬁxed in 4% paraformaldehyde in ASW
and washed with PBS before being treated with 0.1% Triton X-100 for
20 min. After 3 washes with PBS-Tween 20, oocytes and embryos
were blocked for an hour at room temperature in blocking buffer: PBS-
0.05% Tween 20-3% BSA (Sigma; St. Louis, MO). For labeling, the cells
were incubated overnight at 4 1C with either the anti Pm-dysferlin
puriﬁed antibody diluted by 1:500 (ﬁnal concentration: 2 μg/ml) in
blocking buffer, or this antibody pre-incubated for 2 h at room
temperature with the corresponding blocking peptide used at the
ﬁnal concentration of 40 μg/ml. The cells were washed three times
with PBS-Tween 20, and then incubated with an anti-rabbit Alexa
Fluor 488 (green) (Life technologies, Grand Island, NY), diluted by
1:500 in blocking buffer for two hours at room temperature. Oocytes
and embryos were then washed 3 times with PBS-Tween 20. Images
were captured using a LSM 510 laser scanning confocal microscope
(Carl Zeiss, Inc.; Thornwood, NY).
Morpholino injection
Oocytes were injected with the dysferlin morpholino 50- TCGACA-
CAATCACCATCAGCGACAT-30 and incubated for 36 h before in vitro
maturation. An irrelevant morpholino (the sea urchin, Strongylocen-
trotus purpuratus, SCP2) was used as a control: 50-GGACATACTTGT-
CAGGTCGTGCCAA-30. The injection solution contained 1mM of
morpholino. Each young and full-grown oocyte received approxi-
mately 1.4 and 0.5 nM of morpholino respectively. Embryos were
imaged on a Zeiss Axiovert 200 M microscope equipped with a Zeiss
color AxioCam MRc5 camera (Carl Zeiss, Inc.; Thornwood, NY).
In vitro endocytosis assay
Morpholinos injected oocytes were incubated in FSW for
36–48 h at 16 1C and then transferred to ﬁltered sea water
containing 15 μg/ml of FM1-43 (Molecular Probes, Grand Island,
NY) and incubated for additional 3–4 h at 16 1C. Oocytes were then
washed in FSW and observed at the confocal microscope for
monitoring the presence of endocytic vesicles.
Results
Dysferlin is enriched in the plasma membrane of oocytes
To identify the proteins expressed in the plasma membrane of the
full-grown immature oocytes, the surface was labeled with RITC and
the labeled membranes were isolated (Fig. 1A). Proteins obtained from
whole oocytes or plasma membrane-enriched fractions (PMEFs) were
electrophoresed in a 4%–20% SDS-PAGE and visualized by Coomassie
Blue staining and by RITC ﬂuorescence imaging (Fig. 1B). Two bands of
high molecular mass, ﬂanking the 182 kDa marker (n) were repro-
ducibly observed in the plasma membrane fraction. These were
prepared for mass spectrometry analysis and the resulting peptide
sequences were identiﬁed by a SEQUEST search against the P. miniata
ovary transcriptome (Adrian Reich and Gary Wessel, unpublished
data). Dysferlin was identiﬁed with two dysferlin peptides from both
bands (Fig. S1). The largest dysferlin transcript (Pm 1104) found in the
Pm transcriptome contains an open reading frame of 6240 nucleotides
that encodes for a 2080 aa protein, with an expected size of 233 kDa.
An afﬁnity-puriﬁed rabbit polyclonal antibody was generated against
Pm-dysferlin and immunoblot analysis on the PMEF led to a speciﬁc
signal surrounding the 182 kDmarker (Fig.1B), supporting the identity
of the isolated protein. PMEFs were also isolated from a second sea
star species, Asterias forbesi (Af), and a main band, also present at
182 kDa, was observed (Fig. S2). An Af-dysferlin transcript was identi-
ﬁed from the Af ovary transcriptome (Adrian Reich and Gary Wessel,
unpublished data), and similar to the Pm-dysferlin, it contained an
open reading frame of 6231 nucleotides, encoding a cognate protein of
2077 amino acids in length.
Dysferlin is highly conserved between human and sea star
The alignment of amino acid sequences indicates that Pm-
dysferlin is highly conserved with the human dysferlin: Pm and Af-
dysferlin are 85.6% identical and 92.4% similar. Human dysferlin
shares 46.9% of identity and 63.2% of similarity with Pm, and 46.9%
of identity and 63.7% of similarity with Af. Moreover, the same
domains are found in the dysferlins of these three species (Fig. S3).
In both human and sea star, dysferlin contains six main C2
domains. The C2 domain (approximately 130 residues) was ﬁrst
identiﬁed in the Ca2þ-dependent protein kinase C (PKC) and is
involved in Ca2þ-dependent membrane binding. It is also found in
presynaptic proteins such as synaptotagmins (Cho and Stahelin,
2006). Dysferlin also contains two highly conserved DysF domains
that are tandemly repeated. The presence or absence of this
domain in ferlin family members is used to deﬁne two subgroups:
dysferlin and myoferlin (presence) and otoferlin (absence)
(Lek et al., 2012; Lek et al., 2010), although the role of this domain
is not fully understood. However, the DysF domain appears more
susceptible to retain mutations and is involved in dysferlinopathy
(Patel et al., 2008). FerA and FerB, which lie in the long stretch
between C2C and C2D, are also conserved between human and sea
star and both domains are unique to ferlin proteins. FerB is
conserved in all ferlins, while FerA is only found in DysF contain-
ing ferlins (Type 1), suggesting FerA and DysF may have comple-
mentary or additive function (Lek et al., 2010). The FerI domain,
which lies between the C2B and C2C domains, is conserved in Hs,
Pm and Af. This domain was also identiﬁed in ferlin-like proteins of
protozoan Apicomplexan parasites Plasmodium (malaria), Thei-
leria (East Coast fever), Babesia (tick fever), and Toxoplasma
(toxoplasmosis), that account for signiﬁcant worldwide mortality
and morbidity amongst humans and livestock (Lek et al., 2010).
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Finally, human and sea star dysferlin contain a transmembrane
domain similarly placed near the C-terminus of the protein (Bansal
and Campbell, 2004).
The dysferlin transcript is expressed throughout oogenesis and
embryogenesis in sea star
To determine the temporal expression of the dysferlin transcript
in Pm, an RNA probe was synthesized for in situ hybridization and
a probe against the neomycin-resistance gene was used as a
negative control (Fig. 2A). Pm-dysferlin mRNA accumulates uni-
formly in the stages tested, from young oocytes (100 μm diameter)
to gastrula. Quantitative PCR was used to measure the relative RNA
level in young oocytes, full-grown immature oocytes (4160 μm),
mature oocytes, fertilized eggs, two-cell stage, blastula and gas-
trula (Fig. 2B). All values were normalized against Pm-ubiquitin
mRNA. Although differences were seen in qPCR signals, these were
not signiﬁcantly different (p40.05) between the 100 μm oocytes
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and each of the other stages. These results indicate that the
transcript level of dysferlin in Pm uniformly accumulates through-
out oogenesis and early development.
The dysferlin protein is enriched in the plasma membranes of oocytes
and embryos
An afﬁnity-puriﬁed rabbit polyclonal antibody was generated
against Pm-dysferlin and used to determine dysferlin localization
by immunoﬂuorescence (Fig. 3). Pm-dysferlin is detected at the
cortex of the oocytes during oogenesis. Interestingly, dysferlin is
highly expressed in young oocytes (Fig. 3a) and decreases in full-
grown immature oocytes (Fig. 3b). Pm-dysferlin is barely detectable
in mature oocytes (Fig. 3c) but is readily detectable at the plasma
membrane right after fertilization (Fig. 3d) and at the two-cell stage
(Fig. 3e). The protein is also detected in blastula (Fig. 3f) and gastrula
stages (Fig. 3g). No immunoﬂuorescence signal was detected under
the same conditions when the cells were exposed to the Pm-dysferlin
antibody preincubated with the corresponding blocking peptide
(Fig. 3o–u). Moreover, the expression of Pm-dysferlin protein in
oocytes was further tested by Western blot analysis after enrichment
of the plasma membranes (Fig. 4). A similar level of Pm-dysferlin was
obtained in the fractions from immature and mature oocytes,
suggesting that in mature oocytes, even though the protein cannot
be detected by immunoﬂuorescence, Pm-dysferlin is present and
associated with the plasma membrane.
Endocytosis is reduced in Pm-dysferlin knockdown oocytes
To test if dysferlin plays a role in endocytosis during oogenesis
in the sea star, a morpholino was injected into young oocytes to
block dysferlin translation (Fig. 5). Although these dysferlin-
depleted oocytes remained viable, endocytosis was decreased by
more than 40% in the dysferlin injected oocytes, compared to
oocytes injected with a control morpholino (Fig. 5A and B). The
efﬁciency of the morpholino was tested by immunoﬂuorescence
using the antibody against Pm-dysferlin, and quantiﬁcation
revealed that the morpholino reduced the protein expression by
35% (Fig. 5C and D), suggesting that not only was dysferlin actively
being synthesized in the oocyte, it was also being actively
degraded. A strong correlation was seen between the decrease in
endocytosis and the decrease in dysferlin expression.
Pm-dysferlin knockdown induces a developmental arrest at
gastrula stage
To determine the function of dysferlin during embryonic
development in the sea star, the same morpholino was injected
into full-grown immature oocytes. Injection of dysferlin morpho-
linos did not affect oocyte maturation, fertilization, or early
development in Pm when compared to the control (data not
shown). Interestingly, dysferlin morpholino-injected embryos
were smaller and arrested at gastrula (Fig. 6A). The dysferlin
knockdown led to a disorganization of the mesenchyme cells
and the archenteron. The efﬁciency of the morpholino was tested
by immunoﬂuorescence using the antibody against Pm-dysferlin
(Fig. 6B); the morpholino decreased the expression of the protein
signiﬁcantly, on average by 30% during this developmental win-
dow (Fig. 6C).
Discussion
Dysferlin is a transmembrane protein involved in membrane
fusion and membrane repair but a paucity of information limits
Fig. 3. The Pm-dysferlin protein is expressed during oogenesis and embryogenesis. Immunoﬂuorescence using the antibody against Pm-dysferlin (a–g) on 100 μm diameter
oocytes (a), full-grown immature oocytes (b), mature oocytes (c), fertilized eggs (d), two-cell stage (e), blastula (f), and gastrula (g). The corresponding bright ﬁeld images are
respectively shown in a0–g0 . To test the speciﬁcity of the Pm-dysferlin antibody, a control of immunoﬂuorescence was performed by pre-incubating this antibody with its
corresponding blocking peptide (o–u). The corresponding bright ﬁeld images are respectively shown in o0–u0 . Images were taken using the same microscope settings (laser
intensity, pinhole opening).
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our understanding of its function during oogenesis and embry-
ogenesis. Only one dysferlin transcript was found in the Pm ovary
transcriptome (Pm_1104), but since the complete Pm genome has
not been annotated yet, additional dysferlin isoforms could be
expressed at a lower level and not detected in the transcriptome.
However, three transcripts were found for Pm-otoferlin (Pm_10061,
Pm_54312, Pm_21293) although we did not follow-up on their
function in these cells. We found that dysferlin is highly enriched
in the cortex of oocytes (Fig. 3) though it may also be present
below detectable thresholds in other cellular compartments. In
bovine aortic endothelial cells (BAEC), a GFP-tagged dysferlin was
also found in the nucleus and in the Golgi apparatus (Sharma et al.,
2010). Ferlin domains also have similarity to several nucleolar
protein domains (Staub et al., 2004). The nucleolus is the center of
ribosome biogenesis (Tschochner and Hurt, 2003) but is also able
to immobilize proteins as a post translational regulatory mechan-
ism (Audas et al., 2012).
We learned that dysferlin could be knocked down in young sea
star oocytes by morpholinos (Fig. 5). This result is important since
it shows that the oocyte is constantly undergoing protein turnover
and synthesis of dysferlin, and by extension likely other proteins
as well. Even with dysferlin being a transmembrane protein,
turnover is robust in these cells, opening the opportunity to
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Fig. 5. Endocytosis is reduced in dysferlin knockdown oocytes. (A) Young oocytes were injected by either a control (a) or the dysferlin morpholino (b) and incubated with
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expression of Pm-dysferlin decreases in oocytes after morpholino injection. Immunoﬂuorescence on young oocytes injected with either a control (a) or the dysferlin
morpholino (b). The corresponding bright ﬁeld images are respectively shown in (c) and (d). (D) The ﬂuorescence obtained in (C) was quantiﬁed using Metamorph. Twenty
(with an average size of 13877.2 μm) and twenty two (with an average size of 140.778.2 μm) injected oocytes were used respectively for the control and for dysferlin
morpholino. Signiﬁcant difference (n) was observed between the control morpholino and the dysferlin morpholino using Student0s t-test, Po0.05.
N. Oulhen et al. / Developmental Biology 388 (2014) 94–102 99
knockdown and test other oocyte-associated factors for function-
ality in for example, maturation, fertilization, and early develop-
ment. Dysferlin could be required for the fusion of speciﬁc vesicles
with the plasma membrane to add extra membrane at the fusion
site during oocyte growth, as described in C. elegans during
spermiogenesis (Washington and Ward, 2006) but how this
mechanism might work is not well understood. We could envision
a feedback system whereby if exocytosis is reduced by the
dysferlin knockdown, then endocytosis would be reduced to retain
total plasma membrane surface area. Endocytosis is a critical
process utilized by growing oocytes to import yolk protein
precursors (Brooks and Wessel, 2004; Opresko and Wiley, 1987).
In C. elegans, endocytosis of cell surface proteins was also found to
be critical for the regulation of meiotic maturation in oocytes
(Cheng et al., 2008). Studies in both Xenopus (El-Jouni et al., 2007)
and mouse (Lowther et al., 2011) reveal that endocytosis occurs in
oocytes, and contributes to cAMP signaling to regulate meiotic
arrest. The physiological function of endocytosis in the sea star
oocyte is currently under investigations.
Interestingly, we found by Western blot that the dysferlin
protein is expressed at the plasma membrane in mature oocytes,
even though it is undetectable by immunoﬂuorescence in situ at
this, but not other stages. The antibody is directed against a single
peptide (amino acids 889–902) contained in the DysFN domain
(Fig. S3) and one possible explanation for this paradox is that in
mature oocytes, the protein might have either changed its con-
formation or bound a new partner, preventing the interaction with
the antibody. The DysF domains have maintained high sequence
conservation during evolution (Lek et al., 2010) and in humans,
mutations of this domain leads to dysferlinopathy, almost cer-
tainly due to degradation of the unfolded protein (Patel et al.,
2008). The solution structure of the inner DysF domain of the
dysferlin paralogue myoferlin has been solved. It consists of two
long β-strand (residues 929–939 and 1018–1028) oriented anti-
parallel with each other. The intervening 77 residues form a long
loop which packs against both sides of the central β-hairpin;
several regions of this loop form short stretches of β-strand. The
region annotated by SMART as DysFN supplies the ﬁrst strand and
around two-thirds of the loop and the region annotated as DysFC
provides a third of the loop and the second strand (Patel et al.,
2008). In Pm mature oocytes, the protein also could be post-
translationally modiﬁed near the immune peptide site, resulting in
a change of its conformation. A YinOYang prediction analysis
suggests that serine 896 included in the targeted peptide can be
modiﬁed by phosphorylation and by addition of O-linked β-N-
acetylglucosamine. An additional NetPhos analysis predicts that
serines 896 and 898 can be phosphorylated. These speciﬁc
modiﬁcations might have been lost during the plasma membrane
enrichment, leading to the recognition of the protein by immuno-
blot but not in situ. Moreover, additional modiﬁcations or cleavage
of the protein, outside of the peptide sequence, could also change
the conformation of the entire protein. Sulﬁnator predicts that
four tyrosines in the protein can be sulfated, and ProP predicts
three arginine or lysines that could be used as cleavage sites. In
mouse, dysferlin has been found to interact with the histone
deacetylase 6 via its C2D domain, and with the alpha tubulin
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Fig. 6. Knockdown of Pm-dysferlin leads to a developmental arrest at gastrula stage. (A) Immature oocytes were injected by either a control (a) or the dysferlin morpholino
(b). After maturation and fertilization, the embryos were cultured until the gastrula stage, 72 h after fertilization (72h AF). (B) The expression of Pm-dysferlin decreases in
embryos after morpholino injection. Immunoﬂuorescence on embryos injected with either a control (a) or the dysferlin morpholino (b). The corresponding bright ﬁeld
images are respectively shown in (c) and (d). (C) The ﬂuorescence obtained in (B) was quantiﬁed using Metamorph. Nine and eight injected embryos were used respectively
for the control and for dysferlin morpholino. Signiﬁcant difference (n) was obtained between the control morpholino and the dysferlin morpholino using Student0s test,
Po0.05.
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through its C2A and C2B domain during myogenesis (Azakir et al.,
2010; Di Fulvio et al., 2011). Dysferlin can also form a dimer
in vitro, and in living adult skeletal muscle ﬁbers isolated from
mice. Calcium insensitive C2 domains mediate a high afﬁnity self-
association of dysferlin in a parallel homodimer, leaving the Ca-
sensitive C2A domain free to interact with membranes (Xu et al.,
2011). In Pm mature oocytes, dysferlin could be interacting with
new partners and/or forming dimers, reducing its accessibility
to the antibody and thereby making this reagent a functional
reporter.
Dysferlin is also expressed during early development after
fertilization, and through blastula and gastrula stages (Fig. 3).
Reduction of its expression did not lead to any developmental
defects during the early developmental periods. This may be a
result of low knockdown efﬁciency, but it could also suggest that
dysferlin is not essential right after fertilization, during normal
development. Taking into account the role of dysferlin in mem-
brane wounding in sea urchin 4-cell stage embryos (Covian-Nares
et al., 2010), the main function of this protein, right after fertiliza-
tion, could be in membrane sealing during the rapid cellular
divisions, but is expendable, and perhaps compensated by other
membranous proteins. Interestingly, this reduction of dysferlin
expression leads to a developmental arrest during gastrulation, as
shown by the morpholino injection experiments (Fig. 6). Injection
of the dysferlin morpholino in sea star seems to disorganize the
mesenchyme cells and the archenteron. These data suggest that
dysferlin could be required for the cellular rearrangements needed
for the elongation of the archenteron, and/or for cellular signaling
that may be important for stimulating this process. Sea stars
appear to be a good model to study the function of dysferlin and
the role of each domain within a context of oogenesis and
embryogenesis.
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